Literature DB >> 31536800

Is Toxoplasma gondii a potential risk factor for Alzheimer's disease? A systematic review and meta-analysis.

Tooran Nayeri Chegeni1, Shahabeddin Sarvi2, Mahmood Moosazadeh3, Mehdi Sharif4, Sargis A Aghayan5, Afsaneh Amouei6, Zahra Hosseininejad7, Ahmad Daryani8.   

Abstract

Toxoplasmosis is a major public health concern due to neurotropic nature and role in the development of mental and behavioral disorders. Alzheimer's disease (AD) is an important nervous disease that results in the reduction of the amount of beta-amyloid plaque deposition and irreversible loss of neurons in the brain. Although a few studies evaluated the association between AD and toxoplasmosis, the present study as a systematic review and meta-analysis of published studies investigated the possible association between Toxoplasma gondii (T. gondii) and AD. A systematic literature search was conducted using seven electronic databases from the inception to 25th of November 2018 with no restriction of language that looked at toxoplasmosis (as an exposure) and AD (as a disease). The random effect model was used to determine the total odds ratio (OR) and total p-value. Generally, eight studies containing 3239 subjects (360 patients and 2879 controls) met the eligibility criteria. Then, eight articles were used for meta-analysis with respect to inclusion and exclusion criteria. The results of the meta-analysis (random effect model) showed a common OR of 1.53 (95% CI: 1.07-2.18). Despite the fact that there was no evidence of publication bias (P = 0.079) using formal statistical test, the visual inspection of the funnel graph suggested that the observed effect was fueled mainly by three studies with large effects (and large standard errors). Moreover, the file-drawer effect (i.e. publishing mainly studies with positive results) might play a role in the phenomenon. Results of this meta-analytic study suggested that T. gondii can be considered a risk factor for the development of AD and exacerbation of its symptoms. However, the number of published relevant studies is still relatively low, and the risk of the presence of publication bias is relatively high. Therefore, the investigation of the clinically important question of the possible association between toxoplasmosis and AD definitively deserves further attention.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer; Prevalence; Seroprevalence; Toxoplasma; Toxoplasmosis

Mesh:

Year:  2019        PMID: 31536800     DOI: 10.1016/j.micpath.2019.103751

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  16 in total

1.  Association between infection with Toxoplasma gondii and psychiatric disorders.

Authors:  Alia Maisarah; Suharni Mohamad; Maruzairi Husain; Sarimah Abdullah; Rahmah Noordin
Journal:  Folia Parasitol (Praha)       Date:  2022-04-04       Impact factor: 2.122

2.  Toxoplasma gondii infection and risk of attention-deficit hyperactivity disorder: a systematic review and meta-analysis.

Authors:  Tooran Nayeri; Shahabeddin Sarvi; Mahmood Moosazadeh; Zahra Hosseininejad; Afsaneh Amouei; Ahmad Daryani
Journal:  Pathog Glob Health       Date:  2020-03-18       Impact factor: 2.894

Review 3.  Catastrophic consequences: can the feline parasite Toxoplasma gondii prompt the purrfect neuroinflammatory storm following traumatic brain injury?

Authors:  Tamara L Baker; Mujun Sun; Bridgette D Semple; Shiraz Tyebji; Christopher J Tonkin; Richelle Mychasiuk; Sandy R Shultz
Journal:  J Neuroinflammation       Date:  2020-07-25       Impact factor: 8.322

4.  Toxoplasma gondii Effects on the Relationship of Kynurenine Pathway Metabolites to Acoustic Startle Latency in Schizophrenia vs. Control Subjects.

Authors:  Bradley D Pearce; Nicholas Massa; David R Goldsmith; Zeal H Gandhi; Allison Hankus; Alaaeddin Alrohaibani; Neha Goel; Bruce Cuthbert; Molly Fargotstein; Dana Boyd Barr; Parinya Panuwet; Victoria M Brown; Erica Duncan
Journal:  Front Psychiatry       Date:  2020-11-20       Impact factor: 4.157

5.  Latent Toxoplasma gondii infections are associated with elevated biomarkers of inflammation and vascular injury.

Authors:  Andrey I Egorov; Reagan R Converse; Shannon M Griffin; Jennifer N Styles; Elizabeth Sams; Edward Hudgens; Timothy J Wade
Journal:  BMC Infect Dis       Date:  2021-02-18       Impact factor: 3.090

Review 6.  Toxoplasma gondii: A possible etiologic agent for Alzheimer's disease.

Authors:  Tooran Nayeri; Shahabeddin Sarvi; Mehdi Sharif; Ahmad Daryani
Journal:  Heliyon       Date:  2021-06-03

Review 7.  Pathophysiological Mechanisms of Cognitive Impairment and Neurodegeneration by Toxoplasma gondii Infection.

Authors:  Gloria Ortiz-Guerrero; Rodrigo E Gonzalez-Reyes; Alejandra de-la-Torre; German Medina-Rincón; Mauricio O Nava-Mesa
Journal:  Brain Sci       Date:  2020-06-12

8.  The influence of exposure to Toxoplasma Gondii on host lipid metabolism.

Authors:  Fei Xu; Xiwan Lu; Ruitang Cheng; Yuwei Zhu; Sunhan Miao; Qinyi Huang; Yongliang Xu; Liying Qiu; Yonghua Zhou
Journal:  BMC Infect Dis       Date:  2020-06-15       Impact factor: 3.090

Review 9.  Latent Toxoplasmosis Effects on Rodents and Humans: How Much is Real and How Much is Media Hype?

Authors:  Hannah J Johnson; Anita A Koshy
Journal:  mBio       Date:  2020-03-17       Impact factor: 7.867

10.  Licensed Anti-Microbial Drugs Logical for Clinical Trials against Pathogens Currently Suspected in Alzheimer's Disease.

Authors:  Leslie C Norins
Journal:  Antibiotics (Basel)       Date:  2021-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.